Md. firm gets $23 million to develop antidote auto-injector

Emergent Biosolutions Inc., a life sciences company based in Gaithersburg, was awarded a contract worth about $23 million through a Department of Defense initiative. Under the five-year agreement, Emergent will develop a new multi-drug auto-injector for a nerve agent antidote, designed to be used in military situations and in civilian emergencies. Emergent must also demonstrate the device's usability as well ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *